Latham & Watkins LLP represented the underwriters in the offering. Rocket Pharmaceuticals, Inc. has announced the pricing of an upsized underwritten public offering of 4,642,858 shares…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
